Tectonic Therapeutic, Inc. (TECX : NASDAQ)
Common Stock
$27.91
USD
+0.00 (%)
Last updated: 2026-09-17
Get TECX alerts:
TECX
Tectonic Therapeutic, Inc.
Performance
1 Day
-2.10%
1 Week
-8.43%
1 Month
-17.55%
YTD
-7.15%
Key Statistics
Market Cap
$545.62M
52W High
$39.53
52W Low
$14.38
P/E Ratio
-
50 Day MA
$32.42
200 Day MA
$27.67
Beta
0.22
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $28.15 | $28.71 | $27.11 | $27.21 | $27.21 | 186,688 |
| 9/16/2026 | $28.50 | $29.23 | $27.68 | $27.91 | $27.91 | 187,414 |
| 9/15/2026 | $29.71 | $30.02 | $27.95 | $28.51 | $28.51 | 220,901 |
| 9/14/2026 | $29.39 | $30.73 | $29.38 | $29.71 | $29.71 | 145,004 |
| 9/11/2026 | $29.03 | $29.39 | $28.56 | $29.05 | $29.05 | 154,980 |
| 9/10/2026 | $30.06 | $30.32 | $28.40 | $28.61 | $28.61 | 252,400 |
| 9/9/2026 | $30.18 | $31.00 | $29.81 | $30.48 | $30.48 | 133,400 |
| 9/8/2026 | $30.32 | $31.41 | $29.96 | $30.40 | $30.40 | 116,600 |
| 9/4/2026 | $29.85 | $31.12 | $29.74 | $30.75 | $30.75 | 159,300 |
| 9/3/2026 | $30.68 | $32.52 | $29.45 | $29.92 | $29.92 | 140,400 |
Analyst Price Targets
Based on 6 analysts covering TECX · as of Sep 17, 2026
Wall Street analysts forecast TECX stock price to rise 177.9% over the next 12 months.
Consensus
Strong Buy4.83 / 5.00
Avg. Target
US$77.56
+177.9% Upside
Current Price
US$27.91
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TECX's historical volatility
30-Day Vol
88.1%
Annualized
90-Day Vol
77.3%
Annualized
Trend (90d)
-49.2%
Annualized drift
90d Mean
US$22.83
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$25.66 | US$18.93 – US$34.78 |
| 60 trading days | US$24.20 | US$15.74 – US$37.21 |
| 90 trading days | US$22.83 | US$13.48 – US$38.66 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-93.66M
- Profit Margin
- 0.00%
- ROE (TTM)
- -33.80%
- EPS (Diluted)
- -4.46
- Book Value
- 12.24
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About TECX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |